Becton, Dickinson and Company
BDX
$0.84 (-0.42%)
1D
1W
3M
1Y
5Y
ALL
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 2 hours ago • BDX
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision SupportSeeking Alpha • 4 days ago • BDX
DGI For The DIY: 2024 Dividend Portfolio ReviewZacks Investment Research • 13 days ago • BDX
BD Seeks Potential Buyers for Life Sciences Business DivisionPRNewsWire • 18 days ago • BDX
BD to Announce Financial Results for its Second Quarter of Fiscal 2025Reuters • 20 days ago • BDX
​Becton Dickinson in talks to divest life sciences unit, FT reportsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.